WRN-IN-23

Overview

WRN-IN-23 is a Werner Syndrome helicase enzyme ( WRN ) inhibitor. WRN-IN-23 inhibits the ATP-dependent helicase domain activity of WRN. WRN-IN-23 can be used for the research of cancers characterized by microsatellite instability (MSI) and/or defective DNA mismatch repair system (dMMR).

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > DNA/RNA Synthesis

Product Information

• Catalog No.: HY-179326
• CAS No.: 2923008-65-3
• Molecular Formula: C16H20N2O4S
• Molecular Weight: 336.41
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source